Comparison of lovastatin and bezafibrate on lipoprotein(a) plasma levels in cardiac transplant recipients

Am J Cardiol. 1995 Mar 15;75(8):648-50. doi: 10.1016/s0002-9149(99)80642-0.

Abstract

Our results suggest that bezafibrate may be useful in the treatment of high Lp(a) levels in heart transplant patients.

Publication types

  • Clinical Trial
  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Bezafibrate / pharmacology*
  • Female
  • Heart Transplantation*
  • Humans
  • Hyperlipidemias / blood*
  • Hyperlipidemias / drug therapy
  • Lipids / blood
  • Lipoprotein(a) / blood
  • Lipoprotein(a) / drug effects*
  • Lovastatin / pharmacology*
  • Male
  • Middle Aged
  • Prospective Studies

Substances

  • Lipids
  • Lipoprotein(a)
  • Lovastatin
  • Bezafibrate